Impact of Treatment End Point Definitions on Perceived Differences in Long-Term Outcome With Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia [Hematologic Malignancies]
Posted by rob on September 30, 2011 under Uncategorized | 
Comments are off for this article
Conclusion
Uniform definitions of PFS and EFS are needed to compare the long-term efficacy and potential use of different TKIs in CML. (Source: Journal of Clinical Oncology)
MedWorm Message: Please listen to this plea of support for the health workers in Bahrain.